Genmab A/S (GNMSF)
337.00
+9.30
(+2.84%)
USD |
OTCM |
Aug 25, 16:00
Genmab Price : 337.00 for Aug. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 25, 2026 | 337.00 | 337.00 | 337.00 | 337.00 | 30.00 |
| Aug 24, 2026 | 327.70 | 327.70 | 327.70 | 327.70 | 8.000 |
| Aug 21, 2026 | 337.00 | 337.00 | 337.00 | 337.00 | 288.00 |
| Aug 20, 2026 | 335.00 | 335.00 | 335.00 | 335.00 | 40040.00 |
| Aug 19, 2026 | 320.00 | 320.00 | 320.00 | 320.00 | 0.000 |
| Aug 18, 2026 | 320.00 | 320.00 | 320.00 | 320.00 | 147.00 |
| Aug 17, 2026 | 320.00 | 320.00 | 320.00 | 320.00 | 4952.00 |
| Aug 14, 2026 | 310.62 | 310.62 | 310.62 | 310.62 | 0.000 |
| Aug 13, 2026 | 310.62 | 310.62 | 310.62 | 310.62 | 29.00 |
| Aug 12, 2026 | 311.51 | 311.51 | 311.51 | 311.51 | 0.000 |
| Aug 11, 2026 | 311.51 | 311.51 | 311.51 | 311.51 | 0.000 |
| Aug 10, 2026 | 311.51 | 311.51 | 311.51 | 311.51 | 0.000 |
| Aug 07, 2026 | 300.00 | 311.51 | 300.00 | 311.51 | 1700.00 |
| Aug 06, 2026 | 285.25 | 295.00 | 285.25 | 295.00 | 248.00 |
| Aug 05, 2026 | 290.00 | 290.00 | 290.00 | 290.00 | 30.00 |
| Aug 04, 2026 | 290.00 | 290.00 | 289.72 | 289.72 | 146.00 |
| Aug 03, 2026 | 282.00 | 282.00 | 282.00 | 282.00 | 25.00 |
| Jul 31, 2026 | 289.16 | 289.16 | 289.16 | 289.16 | 19000.00 |
| Jul 30, 2026 | 289.16 | 289.16 | 289.16 | 289.16 | 17364.00 |
| Jul 29, 2026 | 289.16 | 289.16 | 289.16 | 289.16 | 0.000 |
| Jul 28, 2026 | 289.16 | 289.16 | 289.16 | 289.16 | 66.00 |
| Jul 27, 2026 | 286.00 | 286.00 | 286.00 | 286.00 | 182.00 |
| Jul 24, 2026 | 274.50 | 274.50 | 274.50 | 274.50 | 0.000 |
| Jul 23, 2026 | 274.50 | 274.50 | 274.50 | 274.50 | 0.000 |
| Jul 22, 2026 | 274.50 | 274.50 | 274.50 | 274.50 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ascendis Pharma A/S | 252.99 |
| Zealand Pharma A/S | 51.80 |
| Bavarian Nordic A/S | 11.28 |
| Evaxion AS | 3.35 |
| ACADIA Pharmaceuticals, Inc. | 30.57 |
Price Related Metrics
| PE Ratio | 26.62 |
| PS Ratio | 5.199 |
| Price to Book Value | 3.377 |
| Price to Free Cash Flow | 24.11 |
| Earnings Yield | 3.76% |
| Market Cap | 20.12B |
| Operating PE Ratio | 16.10 |
| Normalized PE Ratio | 21.82 |